Khaled Sanber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Khaled Sanber has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Zakaria Gad
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children’s Hospital, Houston, Texas
33 shared publications - Meenakshi Hegde
Baylor College of Medicine, Houston, Texas, United States
33 shared publications - Nabil Ahmed
Division of Hematology and Oncology, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Cancer and Hematology Center, Texas Children’s Hospital, Houston, USA
33 shared publications - Shoba Alaska Navai
Division of Hematology/Oncology, Department of Pediatrics Baylor College of Medicine Houston Texas USA
33 shared publications - Zeid Nawas
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas
33 shared publications - Alesandra S. Echeandia Marrero
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas
32 shared publications
Latest Publications
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
PD-L1 expression in glioblastoma (GBM) cells and PD-1 upregulation in CART.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
PD-L1 expression in glioblastoma (GBM) cells and PD-1 upregulation in CART.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Summary of CAR and CPR constructs evaluated in functional assays
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Summary of CAR and CPR constructs evaluated in functional assays
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Immunohistochemistry and histopathology findings in a metastatic osteosarcoma model after treatment with CARζ/CPR41BB cells.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Immunohistochemistry and histopathology findings in a metastatic osteosarcoma model after treatment with CARζ/CPR41BB cells.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Analysis of CAR immune synapse (CARIS) with HER2+ GBM cells.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Analysis of CAR immune synapse (CARIS) with HER2+ GBM cells.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Assessment of PD-L1 expression and CARζ/CPR41BB cell cytotoxic function in osteosarcoma.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Assessment of PD-L1 expression and CARζ/CPR41BB cell cytotoxic function in osteosarcoma.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Summary of CPR/CART design and characterization of CARζ co-expressing CPR containing CD28 or 4-1BB signaling.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Summary of CPR/CART design and characterization of CARζ co-expressing CPR containing CD28 or 4-1BB signaling.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Immunophenotype and functional profile of CARζ/CPR41BB in comparison to CAR41BBζ cells.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Immunophenotype and functional profile of CARζ/CPR41BB in comparison to CAR41BBζ cells.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
In vivo function of systemically administered CARζ/CPR41BB cells in a metastatic osteosarcoma model.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
In vivo function of systemically administered CARζ/CPR41BB cells in a metastatic osteosarcoma model.
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Analysis of CAR immune synapse (CARIS) formation by CARζ/CPR41BB and CAR41BBζ cells with wild-type and PD-L1 KO LN229-GBM cells.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function
Analysis of CAR immune synapse (CARIS) formation by CARζ/CPR41BB and CAR41BBζ cells with wild-type and PD-L1 KO LN229-GBM cells.